Navigation Links
Booster Dose for Chickenpox Vaccine Recommended

A study has been released by U.S scientists working for the Centers of Disease Control, Atlanta, that suggest immunity from chickenpox// conferred by Varicella vaccine may wane over the years, and even result in a more severe form of the disease. The study findings encourage a booster dose of the vaccine.

In the surveillance data, children vaccinated five or more years earlier were 2.6 times more likely to have a moderate-to-severe breakthrough case of chickenpox than those who had been vaccinated more recently.

Lead researcher Sandra S. Chaves and team have reported that the breakthrough varicella rate eight years after vaccination, was 12 times higher than in the first year after vaccination, even accounting for changes in exposure.

Findings were published in the New England Journal.

Says Chavez who came about the findings after following a sentinel population of 350, 000 subjects for 10 years after the implementation of universal varicella vaccination in 2005, “ Waning of immunity is of particular public health interest because it may result in increased susceptibility later in life, when the risk of severe complications may be greater than that in childhood."

Dr. Jane Seward, one of the authors of the study and an official at CDC, Atlanta, said that researchers decided to embark on the study after noticing outbreaks were happening despite vaccination programs.

Seward said the chickenpox vaccine provides 85 per cent protection, but of the remaining 15 per cent, most will get mild cases of chicken pox -- with a small number getting more severe illness.

It has been demonstrated that immunity from varicella vaccination wanes among health care workers in terms of measurable antibodies, but this is the first study to demonstrate that vaccination-induced immunity breaks down over time in children.
ANN
'"/>




Page: 1

Related medicine news :

1. Need for Hepatitis Booster Questioned
2. Booster dose not required for Hepatitis B Vaccination
3. Booster Dose Of Radiotherapy Beneficial In Early Breast Cancer
4. The Effectiveness Of Chickenpox Vaccine Questioned
5. Vaccine To Stop the Spread of Chickenpox
6. Maldives Volleyball Team Members Affected by Chickenpox
7. Vaccine to quit smoking?
8. First Vaccine Designed for Africa Cleared for Testing in Humans
9. Vaccine for Alzheimer’s diseas
10. Health Officials Recommend Flu Vaccine
11. Smallpox Vaccine May Help Fight Cervical Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/21/2017)... , ... September 21, 2017 , ... ... their communities, nine governmental public health departments have been awarded five-year accreditation status ... mean that the benefits of being served by a PHAB-accredited health department ...
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... The New ... with autism, announced today the election of Yie-Hsin Hung to the Board of Directors. ... join our Board of Directors. Ms. Hung is an invaluable addition to our team,” ...
(Date:9/21/2017)... ... September 21, 2017 , ... FlipBelt, the fitness brand that specializes ... to the athletic wear market with the launch of their FlipBelt Crops. , The ... essentials securely at their fingertips while at the gym, on the trail, or on-the-go. ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... Prescott, Arizona, is now accredited by The Joint Commission for chemical dependency and ... accredits and certifies U.S. health care organizations that meet the commission’s rigorous standards. ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... voice for people who have kidney disease. The theme “Describe a positive decision ... stories. Entrants needed to meet only one qualification— to have been diagnosed ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... FRANCISCO , Sept. 12, 2017  ValGenesis ... Management Solutions (VLMS), is pleased to announce the ... a member of its Board of Directors and ... ValGenesis VLMS enables life science companies to manage ... the use of paper in this process. Furthermore, ...
(Date:9/9/2017)... , Sept. 9, 2017  Eli Lilly and Company ... and secondary endpoint data for lasmiditan, an investigational, oral, ... demonstrated statistically significant improvements compared to placebo in the ... today at the 18th Congress of the International Headache ... "The data presented today demonstrate lasmiditan,s potential to ...
(Date:9/7/2017)... , Sept. 7, 2017 Caris Life ... on fulfilling the promise of precision medicine, today ... the benefits of its molecular profiling approach in ... comprehensive genomic profiling plus (CGP+) with Caris Molecular ... tumor on a molecular level, leading to more ...
Breaking Medicine Technology: